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Abstract. The development of cancer is largely driven by the gain or loss of sub-
sets of the genome, promoting uncontrolled growth or disabling defenses against
it. Identifying genomic regions whose DNA copy number deviates from the nor-
mal is therefore central to understanding cancer evolution. Array-based compar-
ative genomic hybridization (aCGH) is a high-throughput technique for identi-
fying DNA gain or loss by quantifying total amounts of DNA matching defined
probes relative to healthy diploid control samples. Due to the high level of noise in
microarray data, however, interpretation of aCGH output is a difficult and error-
prone task.
In this work, we tackle the computational task of inferring the DNA copy num-
ber per genomic position from noisy aCGH data. We propose CGHTRIMMER, a
novel segmentation method that uses a fast dynamic programming algorithm to
solve for a least-squares objective function for copy number assignment. CGHTRIM-
MER consistently achieves superior precision and recall to leading competitors on
benchmarks of synthetic data and real data from the Coriell cell lines. In addition,
it finds several novel markers not recorded in the benchmarks but plausibly sup-
ported in the oncology literature. Furthermore, CGHTRIMMER achieves superior
results with run-times from 1 to 3 orders of magnitude faster than its state-of-art
competitors.
CGHTRIMMER provides a new alternative for the problem of aCGH discretiza-
tion that provides superior detection of fine-scale regions of gain or loss yet is fast
enough to process very large data sets in seconds. It thus meets an important need
for methods capable of handling the vast amounts of data being accumulated in
high-throughput studies of tumor genetics.
1 Introduction
Tumorigenesis is a complex phenomenon often characterized by the successive acqui-
sition of combinations of genetic aberrations that result in malfunction or disregula-
tion of genes. There are many forms of chromosome aberration that can contribute to
cancer development, including polyploidy, aneuploidy, interstitial deletion, reciprocal
translocation, non-reciprocal translocation, as well as amplification, again with several
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different types of the latter (e.g., double minutes, HSR and distributed insertions [1]).
Identifying the specific recurring aberrations, or sequences of aberrations, that char-
acterize particular cancers provides important clues about the genetic basis of tumor
development and possible targets for diagnostics or therapeutics. Many other genetic
diseases are also characterized by gain or loss of genetic regions, such as Down Syn-
drome (trisomy 21) [24], Cri du Chat (5p deletion) [25], and Prader-Willi syndrome
(deletion of 15q11-13) [5] and recent evidence has begun to suggest that inherited copy
number variations are far more common and more important to human health than had
been suspected just a few years ago [45]. These facts have created a need for methods
for assessing DNA copy number variations in individual organisms or tissues.
In this work, we focus specifically on array-based comparative genomic hybridiza-
tion (aCGH) [4,35,18,34], a method for copy number assessment using DNA microar-
rays that remains, for the moment, the leading approach for high-throughput typing of
copy number abnormalities. The technique of aCGH is schematically represented in
Figure 1. A test and a reference DNA sample are differentially labeled and hybridized
to a microarray and the ratios of their fluorescence intensities is measured for each spot.
A typical output of this process is shown in Figure 1 (3), where the genomic profile of
the cell line GM05296 [39] is shown for each chromosome. The x-axis corresponds to
genomic position and the y-axis corresponds to a noisy measurement of the ratio log2
T
R
for each genomic position. For healthy diploid organisms, R=2 and T is the DNA copy
number we want to infer from the noisy measurements. For more details on the use of
aCGH to detect different types of chromosomal aberrations, see [1].
Converting raw aCGH log fluorescence ratios into discrete DNA copies numbers
is an important but non-trivial problem in using aCGH to study cancer progression.
Finding DNA regions that consistently exhibit chromosomal losses or gains in cancers
provides a crucial means for locating the specific genes involved in development of dif-
ferent cancer types. It is therefore important to distinguish, when a probe shows unusu-
ally high or low fluorescence, whether that aberrant signal reflects experimental noise
or a probe that is truly found in a segment of DNA that is gained or lost. Furthermore,
successful discretization of array CGH data is crucial for understanding the process of
cancer evolution, since discrete inputs are required for a large family of successful evo-
lution algorithms, e.g., [8,9]. It is worth noting that manual annotation of such regions,
even if possible [39], is tedious and prone to mistakes due to several sources of noise
(impurity of test sample, noise from array CGH method, etc.).
Many algorithms and objective functions have thus been proposed for the problem
of discretizing and segmenting aCGH data. Many methods, starting with Fridlyand et
al. [11], treat aCGH segmentation as a hidden Markov model (HMM) inference prob-
lem. The HMM approach has since been extended in various ways, such as through
the use of Bayesian HMMs [12], incorporation of prior knowledge of locations of
DNA copy number polymorphisms [37], and the use of Kalman filters [38]. Other
approaches include wavelet decompositions [14], quantile regression [10], expectation-
maximization in combination with edge-filtering [27], genetic algorithms [17], clustering-
based methods [44,42], variants on Lasso regression [40,15], and various problem-
specific Bayesian [2], likelihood [16], and other statisical models [26]. A dynamic
programming approach, in combination with expectation maximimization, has been
Fig. 1. Schematic representation of array CGH. Genomic DNA from two cell popu-
lations (1) is differentially labeled and hybridized in a microarray (2). Typically the
reference DNA comes from a normal subject. For humans this means that the reference
DNA comes from a normal diploid genome. The ratios on each spot are measured and
normalised so that the median log2 ratio is zero. The final result is an ordered tuple con-
taining values of the fluorescent ratios in each genomic position per each chromosome.
This is shown in (3) where we see the genomic profile of the cell line GM05296 [39].
The problem of denoising array CGH data is to infer the true DNA copy number T per
genomic position from a set of noisy measurements of the quantity log2
T
R , where R=2
for normal diploid humans.
previously used by Picard et al. [33]. Lai et al. [21] and Willenbrock et al. [43] have
conducted extensive experimental analysis of the range of available methods, with two
in particular standing out as the leading approaches in practice. One of these top meth-
ods is CGHSEG [32], which assumes that a given CGH profile is a Gaussian pro-
cess whose distribution parameters are affected by abrupt changes at unknown coor-
dinates/breakpoints. The other is Circular Binary Segmentation [30] (CBS), a modifi-
cation of binary segmentation, originally proposed by Sen and Srivastava [36], which
uses a statistical comparison of mean expressions of adjacent windows of nearby probes
to identify possible breakpoints between segments combined with a greedy algorithm
to locally optimize breakpoint positions.
Our main contribution in this work is a new algorithm, CGHTRIMMER, for denois-
ing and segmentation of aCGH data. We develop a novel objective function for the
problem based on least-squares minimization of errors combined with a regularization
parameter to favor contiguity across segments. We show how to solve efficiently for
this objective function through dynamic programming. We then validate the method, in
comparison to the leading CBS and CGHSEG methods, on a combination of synthetic
and real benchmarks. Finally, we show that CGHTRIMMER yields superior accuracy in
identifying known breakpoints while performing one to three orders of magnitude faster
than the comparative methods. The remainder of the paper is organized as follows: Sec-
tion 2 presents our proposed method and its theoretical analysis. Section 3 describes the
experimental setup and shows the experimental results of our method compared to two
Symbol Description
pi measurement of log2
T
R
in the i-th probe
n number of probes
T DNA copy number
R reference value, equal to 2 for diploid organisms
K number of segments to be fitted
λ regularization parameter
µ(j) Average of points {p1, . . . , pj}, µ(j) =
∑j
i=1 pi/j
S(j) Sum of squared errors
∑j
i=1(pi − µ(j))2
CBS Circular binary segmentation [30]
CGHSEG Picard et al. [32]
Table 1. Symbols and abbreviations used.
state-of-art methods [30,32] on both synthetic and real aCGH data. Section 4 concludes
the paper with a brief summary and discussion.
2 Proposed Method
We formulate the problem of denoising aCGH data as a least squares problem with
a penalty/regularization term for the number of segments. Table 1 shows the symbols
used throughout the paper for convenience. Let P = {p1, . . . , pn} be a set of n points,
pi ∈ R. Our goal is to find a sequence of piecewise constant segments which minimize
the sum of squared errors per segment and the number of segments K. Ideally, our
algorithm will fit the data with piecewise constant segments corresponding to the true
DNA copy number at each genomic position. The intuition for penalizing the number
of segments is that we expect a strong spatial coherence between nearby probes. Gains
and losses are likely to occur for DNA segments covering many probes, and adjacent
probes should therefore usually have the same copy number. We avoid making explicit
assumptions about the statistical nature of the signal (although we note that the least
squares method can be interpreted as a maximization of the likelihood function under
the assumption that noise derives from identically distributed Gaussian random vari-
ables) since we do not believe we have a strong empirical basis for exactly capturing
the true correlation structure of aCGH data. To solve this optimization problem, we
define the key quantity OPTi, given by the following equation:
OPTi =

0 if i = 0
min1≤j≤iOPTj−1 +
∑i
k=j
(
pk −
∑i
m=j pm
i−j+1
)2
+ λ if i > 0
(1)
The recursion equation 1 has a straightforward interpretation: OPTi is equal to the
minimum cost of fitting a set of piecewise constant segments from point p1 to pi given
that the last change in copy numbers occured between points pj−1 and pj plus the cost
of fitting a segment is λ. The second term is the minimum squared error for fitting a
constant segment on points {pj , . . . , pi}, which is obtained for the constant segment
with value equal to the average intensity of the points in the segment, i.e.,
∑i
m=j pm
i−j+1 .
Recursion 1 directly implies a dynamic programming algorithm, the CGHTRIMMER
algorithm presented as Algorithm 1. For each point pi, we find a point pj such that j
is the minimum index over all points before i such that points pj through pi belong
to the same segment. Since aCGH data are given in the log scale, we first exponenti-
ate the points, then fit the constant segment by taking the average of the exponentiated
values from the hypothesized segment, and then return to the log domain by taking
the logarithm of that constant value. Observe that one can fit a constant segment by
averaging the log values using Jensen’s inequality, but we favor an approach more con-
sistent with the prior work, which typically models the data assuming i.i.d. Gaussian
noise in the linear domain. The algorithm decides which points will be assigned to the
same segment by tracing back, starting from the last point pn, using the breakpoint vari-
ables until it assigns the first point p1 to a segment. The main computational bottleneck
of CGHTRIMMER is the computation of an auxiliary matrix M , an upper diagonal
matrix for which mij is the minimum squared error of fitting a segment from points
{pi, . . . , pj}. To avoid a naı¨ve algorithm that would simply find the average of those
points and then compute the squared error, resulting in O(n3) time, we take advantage
of the following theorem:
Algorithm 1 CHGtrimmer algorithm.
Require: Points P = {p1, . . . , pn}
Require: Regularization parameter λ
Compute an n× n matrix M , where
Mji ←∑ik=j (pk − ∑im=j pmi−j+1 )2.
for i = 1 to n do
OPTi ← min1≤j≤iOPTj−1 +Mj,i + λ
BREAKi ← argmin1≤j≤iOPTj−1 +Mj,i + λ
end for
tmp← n {Assign points to segments}
while tmp 6= 0 do
Assign points {pBREAKtmp , . . . , ptmp} to one segment
tmp← BREAKtmp − 1
end while
Theorem 1. Letm(j) and S(j) be the average and the minimum squared error of fitting
a constant segment for points {p1, . . . , pj}. Then the following equations hold:
m(j) =
j − 1
j
m(j−1) +
1
j
pj (2)
S(j) = S(j−1) +
j − 1
j
(pj −m(j−1))2 (3)
Algorithm 2 Computing matrix M efficiently in O(n2)
Require: Points P = {p1, . . . , pn}
Initialize matrix A ∈ Rn×n, Aij = 0, i 6= j and Aii = pi.
Initialize matrix M ∈ Rn×n with zeros.
for i = 1 to n do
for j = i+ 1 to n do
Ai,j ← j−ij−i+1Ai,j−1 + 1j−i+1pj
end for
end for
for i = 1 to n do
for j = i+ 1 to n do
Mi,j ←Mi,j−1 + j−ij−i+1 (pj −Ai,j−1)2
end for
end for
For a proof, see [20]. Equations 2 and 3 provide us a way to compute means and
least squared errors online, leading to the O(n2) Algorithm 2 for computing matrix M .
The resulting method hasO(n2) time and space complexity. The algorithm needs to
store two n× n matrices, M and A, in addition to the size-n OPT and BREAK ma-
trices needed for the dynamic programming. Therefore the space complexity is O(n2).
TheA andM matrices each haveO(n2) entries and requireO(1) time to compute each
entry, while computing theOPTi andBREAKi entries requires at mostO(n) time for
each of n entries. Therefore the total running time is O(n2).
3 Results
Dataset Availability
 Lai et al. [21]
http://compbio.med.harvard.edu/
 Willenbrock et al. [43]
http://www.cbs.dtu.dk/˜hanni/aCGH/
 Coriell Cell lines [39]
http://www.nature.com/ng/journal/v29/n3/
 Berkeley Breast Cancer [28]
http://icbp.lbl.gov/breastcancer/
Table 2. Datasets, papers and the URLs where the datasets can be downloaded.  and
 denote which datasets are synthetic and real respectively.
This section is organized as follows: first we describe the experimental setup and
how we trained our model. Then we present our experimental results on both synthetic
and real data.
3.1 Experimental Setup and Datasets
CGHTRIMMER is implemented in MATLAB. The experiments run in a 4GB RAM,
2.4GHz Intel(R) Core(TM)2 Duo CPU, Windows Vista machine. Our methods were
compared to existing MATLAB implementations of the CBS algorithm, available via
the Bioinformatics toolbox, and the CGHSEG algorithm, generously provided by by
Franc Picard [32]. CGHSEG was run using heteroscedastic model under the Lavielle
criterion [22]. Additional tests using the homoscedastic model showed substantially
worse performance and are omitted here. All methods were compared using previ-
ously developed benchmark datasets, shown in Table 2. Follow-up analysis of detected
regions was conducted by manually searching for significant genes in the Genes-to-
Systems Breast Cancer Database http://www.itb.cnr.it/breastcancer [41]
and validating their positions with the UCSC Genome Browser http://genome.
ucsc.edu/. The Atlas of Genetics and Cytogenetics in Oncology and Haematology
http://atlasgeneticsoncology.org/ was also used to validate the signifi-
cance of reported cancer-associated genes.
Fig. 2.ROC curve of CGHTRIMMER as a function of λ on data from [43]. The red arrow
indicates the point (0.91 and 0.98 recall and precision respectively) corresponding to
λ=0.2, the value used in all subsequent results.
3.2 Picking λ
The performance of our algorithm depends on the value of the parameter λ, which deter-
mines how much each segment “costs.” Clearly, there is a tradeoff between bigger and
smaller values: excessively large λ will lead the algorithm to output a single segment
while excessively small λ will result in each point being fit as its own segment. We pick
our parameter λ using data published in [43]. These data have been generated by mod-
eling real CGH data, thus capturing their nature better than other simplified synthetic
data and also making them a good training dataset for our model. We used this dataset
to generate a Receiver Operating Characteristic (ROC) curve using values for λ ranging
from 0 to 4 with increment 0.01 using one of the four datasets in [43] (“above 20”). The
resulting curve is shown in Figure 2. We then selected λ = 0.2, which achieves high
precision (0.98) and high recall (0.91). All subsequent results reported were obtained
by setting λ equal to 0.2.
(a) CGHTRIMMER (b) CBS
(c) CGHSEG
Fig. 3. Performance of CGHTRIMMER, CBS, and CGHSEG on denoising synthetic
aCGH data from [21]. CGHTRIMMER and CGHSEG exhibit excellent precision and
recall whereas CBS misses two consecutive genomic positions with DNA copy number
equal to 3.
3.3 Synthetic Data
We use the synthetic data published in [21]. The data consist of five aberrations of
increasing widths of 2, 5, 10, 20 and 40 probes, respectively, with Gaussian noise
N(0,0.252). Figure 3 shows the performance of CGHTRIMMER, CBS, and CGHSEG.
Both CGHTRIMMER and CGHSEG correctly detect all aberrations, while CBS misses
the first, smallest region. Run time for CGHTRIMMER is 0.007 sec, compared to 1.23
sec for CGHSEG and 60 sec for CBS.
3.4 Coriell Cell Lines
The first real dataset we use to evaluate our method is the Coriell cell line BAC array
CGH data [39], which is widely considered a “gold standard” dataset. The dataset is
derived from 15 fibroblast cell lines using the normalized average of log2 fluorescence
relative to a diploid reference. To call gains or losses of inferred segments, we assign
each segment the mean intensity of its probes and then apply a simple threshold test
to determine if the mean is abnormal. We follow [3] in favoring ±0.3 out of the wide
variety of thresholds that have been used [29].
Table 3 summarizes the performance of CGHTRIMMER, CBS and CGHSEG rela-
tive to previously annotated gains and losses in the Corielle dataset. The table shows
notably better performance for CGHTRIMMER compared to either alternative method.
CGHTRIMMER finds 22 of 23 expected segments with one false positive. CBS finds
20 of 23 expected segments with one false positive. CGHSEG finds 22 of 23 expected
segments with seven false positives. CGHTRIMMER thus achieves the same recall as
CGHSEG while outperforming it in precision and the same precision as CBS while
outperforming it in recall. In cell line GM03563, CBS fails to detect a region of two
points which have undergone a loss along chromosome 9, in accordance with the results
obtained using the Lai et al. [21] synthetic data. In cell line GM03134, CGHSEG makes
a false positive along chromosome 1 which both CGHTRIMMER and CBS avoid. In cell
line GM01535, CGHSEG makes a false positive along chromosome 8 and CBS misses
the aberration along chromosome 12. CGHTRIMMER, however, performs ideally on
this cell line. In cell line GM02948, CGHTRIMMER makes a false positive along chro-
mosome 7, finding a one-point segment in 7q21.3d at genomic position 97000 whose
value is equal to 0.732726. All other methods also make false positive errors on this cell
line. In GM7081, all three methods fail to find an annotated aberration on chromosome
15. In addition, CGHSEG finds a false positive on chrosome 11.
CGHTRIMMER also substantially outperforms the comparative methods in run time,
requiring 5.78 sec for the full data set versus 8.15 min for CGHSEG (an 84.6-fold
speedup) and 47.7 min for CBS (a 495-fold speedup).
3.5 Breast Cancer Cell Lines
To further illustrate the performance of CGHTRIMMER and compare it to CBS and
CGHSEG, we applied it to the Berkeley Breast Cancer cell line database [28]. The
dataset consists of 53 breast cancer cell lines that capture most of the recurrent ge-
nomic and transcriptional characteristics of 145 primary breast cancer cases. We do
not have an accepted “answer key” for this data set, but it provides a more extensive
basis for detailed comparison of differences in performance of the methods on com-
mon data sets, as well as an opportunity for novel discovery. While we have applied
the methods to all chromosomes in all cell lines, space limitations prevent us present-
ing the full results here. We therefore arbitrarily selected three of the 53 cell lines
Cell Line/Chromosome CGHTRIMMER CBS CGHSEG
GM03563/3 X X X
GM03563/9 X No X
GM03563/False - - -
GM00143/18 X X X
GM00143/False - - -
GM05296/10 X X X
GM05296/11 X X X
GM05296/False - - 4,8
GM07408/20 X X X
GM07408/False - - -
GM01750/9 X X X
GM01750/14 X X X
GM01750/False - - -
GM03134/8 X X X
GM03134/False - - 1
GM13330/1 X X X
GM13330/4 X X X
GM13330/False - - -
GM03576/2 X X X
GM03576/21 X X X
GM03576/False - - -
GM01535/5 X X X
GM01535/12 X No X
GM01535/False - - 8
GM07081/7 X X X
GM07081/15 No No No
GM07081/False - - 11
GM02948/13 X X X
GM02948/False 7 1 2
GM04435/16 X X X
GM04435/21 X X X
GM04435/False - - 8,17
GM10315/22 X X X
GM10315/False - - -
GM13031/17 X X X
GM13031/False - - -
GM01524/6 X X X
GM01524/False - - -
Table 3. Results from applying CGHTRIMMER, CBS, and CGHSEG to 15 cell lines.
Rows with listed chromosome numbers (e.g., GM03563/3) corresponded to known
gains or losses and are annotated with a check mark if the expected gain or loss was
detected or a “No” if it was not. Additional rows list chromosomes on which segments
not annotated in the benchmark were detected; we presume these to be false positives.
and selected three chromosomes per cell line that we believed would best illustrate
the comparative performance of the methods. The Genes-to-Systems Breast Cancer
Database http://www.itb.cnr.it/breastcancer [41] was used to identify
known breast cancer markers in regions predicted to be gained or lost by one or more of
the methods, with the UCSC Genome Browser http://genome.ucsc.edu/ used
to verify the placement of genes.
We note that CGHTRIMMER again had a substantial advantage in run time. For the
full data set, CGHTRIMMER required 22.76 sec, compared to 23.3 min for CGHSEG (a
61.5-fold increase), and 4.95 hrs for CBS (a 783-fold increase).
Cell Line BT474: Figure 4 shows the performance of each method on the BT474
cell line. The three methods report different results for chromsome 1, as shown in Fig-
ures 4(a,b,c), with all three detecting amplification in the q-arm but differing in the detail
of resolution. CGHTRIMMER is the only method that detects region 1q31.2-1q31.3 as
aberrant. This regions hosts gene NEK7, a candidate oncogene [19] and gene KIF14,
a predictor of grade and outcome in breast cancer [7]. CGHTRIMMER and CBS anno-
tate the region 1q23.3-1q24.3 as amplified. This region hosts several genes previously
implicated in breast cancers [41], such as CREG1 (1q24), POU2F1 (1q22-23), RCSD1
(1q22-q24), and BLZF1 (1q24). Finally, CGHTRIMMER alone reports independent am-
plification of the gene CHRM3, a a marker of metastasis in breast cancer patients [41].
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Fig. 4.Visualization of segmentation output of CGHTRIMMER, CBS, and CGHSEG for
cell line BT474 on chromosomes 1 (a,b,c), 5 (d,e,f), and 17 (g,h,i). (a,d,g) CGHTRIM-
MERoutput. (b,e,h) CBSoutput. (c,f,i) CGHSEGoutput.
For chromosome 5 (Figures 4(d,e,f)), the behavior of the three methods is almost
identical, with all three reporting amplification of a region known to contain many
breast cancer markers, including MRPL36 (5p33), ADAMTS16 (5p15.32), POLS (5p15.31),
ADCY2 (5p15.31), CCT5 (5p15.2), TAS2R1 (5p15.31), ROPN1L (5p15.2), DAP (5p15.2),
ANKH (5p15.2), FBXL7 (5p15.1), BASP1 (5p15.1), CDH18 (5p14.3), CDH12 (5p14.3),
CDH10 (5p14.2 - 5p14.1), CDH9 (5p14.1) PDZD2 (5p13.3), GOLPH3 (5p13.3), MTMR12
(5p13.3), ADAMTS12 (5p13.3 - 5p13.2), SLC45A2 (5p13.2), TARS (5p13.3), RAD1
(5p13.2), AGXT2 (5p13.2), SKP2 (5p13.2), NIPBL (5p13.2), NUP155 (5p13.2), KRT18P31
(5p13.2), LIFR (5p13.1) and GDNF (5p13.2) [41]. The only difference in the assign-
ments is that CBS fits one more probe to this amplified segment.
Finally, for chromosome 17 (Figures 4(g,h,i)), like chromosome 1, all three detect
amplification but CGHTRIMMER predicts a finer breakdown of the amplified region
into independently amplified segments. All three detect amplification of a region in-
cluding the major breast cancer biomarkers HER2 (17q21.1) and BRCA1 (17q21) and
the additional markers MSI2 (17q23.2) and TRIM37 (17q23.2) [41]. While the more
discontiguous picture produced by CGHTRIMMER may appear to be a less parsimo-
nious explanation of the data, a complex combination of fine-scale gains and losses in
17q is in fact well supported by the literature [31].
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Fig. 5. Visualization of segmentation output of CGHTRIMMER, CBS, and CGHSEG
for cell line HS578T on chromosomes 3 (a,b,c), 11 (d,e,f), and 17 (g,h,i). (a,d,g)
CGHTRIMMERoutput. (b,e,h) CBSoutput. (c,f,i) CGHSEGoutput.
Cell Line HS578T: Figure 5 compares the methods on cell line HS578T for chro-
mosomes 3, 11 and 17. Chromosome 3 (Figures 5(a,b,c)) shows identical prediction
of an amplification of 3q24-3qter for all three methods, a region including the key
breast cancer markers PIK3CA (3q26.32) [23], and additional breast-cancer-associated
genes TIG1 (3q25.32), MME (3q25.2), TNFSF10 (3q26), MUC4 (3q29), TFRC (3q29),
DLG1 (3q29) [41]. CGHTRIMMER and CGHSEG also have identical predictions of
normal copy number in the p-arm, while CBS reports an additional loss between 3p21
and 3p14.3. We are unaware of any known gain or loss in this region associated with
breast cancer.
For chromosome 11 (Figures 5(d,e,f)), the methods again present an identical pic-
ture of loss at the q-terminus (11q24.2-11qter) but detect amplifications of the p-arm
at different levels of resolution. CGHTRIMMER and CBS detect gain in the region
11p15.5, the site of the HRAS breast cancer metastasis marker [41]. In contrast to CBS,
CGHTRIMMER detects an adjacent loss region. While we have no direct evidence this
loss is a true finding, the region of predicted loss does contain EIF3F (11p15.4), iden-
tified as a possible tumor suppressor whose expression is decreased in most pancreatic
cancers and melanomas [41]. We can thus conjecture that EIF3F is also a tumor sup-
pressor in breast cancers.
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Fig. 6.Visualization of segmentation output of CGHTRIMMER, CBS, and CGHSEG for
cell line T47D on chromosomes 1 (a,b,c), 11 (d,e,f), and 20 (g,h,i). (a,d,g) CGHTRIM-
MERoutput. (b,e,h) CBSoutput. (c,f,i) CGHSEGoutput.
On chromosome 17 (Figures 5(g,h,i)), the three methods behave similarly, with all
three predicting amplification of the p-arm. CBS places one more marker in the am-
plified region causing it to cross the centromere while CGHSEG breaks the amplified
region into three segments by predicting additional amplification at a single marker.
Cell Line T47D: Figure 6 compares the methods on chromosomes 1, 8, and 20 of cell
line T47D. On chromosome 1 (Figure 6(a,b,c)), all three methods detect loss of the
p-arm and predominant amplification of the q-arm. CBS infers a presumably spurious
extension of the p-arm loss across the centromere into the q-arm, while the other meth-
ods do not. The main differences between the three methods appear on the q-arm of
chromosome 1. CGHTRIMMER and CGHSEG both detect a small region of gain prox-
imal to the centromere at 1q21.1-1q21.2, followed by a short region of loss spanning
1q21.3-1q22. CBS merges these into a single longer region of normal copy number.
The existence of a small region of loss at this location in breast cancers is supported by
prior literature [6].
The three methods provide comparable segmentations of chromosome 11 (Fig-
ure 6(d,e,f)). All predict loss near the p-terminus, a long segment of amplification
stretching across much of the p- and q-arms, and additional amplification near the q-
terminus. CGHTRIMMER, however, breaks this q-terminal amplification into several
sub-segments at different levels of amplification while CBS and CGHSEG both fit a
single segment to that region. We have no empirical basis for determining which seg-
mentation is correct here. CGHTRIMMER does appear to provide a spurious break in
the long amplified segment that is not predicted by the others.
Finally, along chromosome 20 (Figure 6(g,h,i)), the output of the methods is similar,
with all three methods suggest that the q-arm has an aberrant copy number, an obser-
vation consistent with prior studies [13]. The only exception is again that CBS fits one
point more than the other two methods along the first segment, causing a likely spurious
extension of the p-arm’s normal copy number into the q-arm.
4 Conclusions
We have presented CGHTRIMMER, a new algorithm for detecting genomic regions of
loss or gain in aCGH data. We compared CGHTRIMMER to two widely used methods,
CBS [30] and CGHSEG [32] that have previously been identified as the most successful
among many options in the literature [21]. CGHTRIMMER shows performance identical
to CGHSEG and superior to CBS on a synthetic benchmark and superior performance
to both on a benchmark of real cell line data. Further demonstration of the methods on
selected regions from a large breast cancer cell line dataset suggests that CGHTRIM-
MER is generally superior at detecting fine-scale variations in aCGH data, while avoid-
ing apparently spurious or misplaced breakpoints assigned by the other methods. Where
results differ between the methods, there is usually good support in the literature for
the CGHTRIMMER segmentation. Furthermore, CGHTRIMMER achieves superior ac-
curacy with run times more than 50-fold faster than CGHSEG and more than 500-fold
faster than CBS.
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